Our vision is driven by the conviction that equitable access to diagnosis is central to achieving good health
Rapid and accurate diagnosis for every patient is a first essential step towards effective treatment and prevention. Yet the diagnostic tools available in the developing world are largely out-dated and ineffective, while those used in wealthier societies are either too expensive or not adapted for use in low-resource settings.
As a result, each year millions of people in low-resource settings still die from diseases that are treatable, like tuberculosis, malaria or sleeping sickness. The lack of appropriate tests also leads to delayed treatment, multiple clinic visits, and misdiagnosis, all of which result in health and financial costs and waste of valuable resources.
We believe that good health is essential to breaking the chronic cycle of poverty and disease
Poverty and poor health are closely intertwined. The toll of illness is a huge burden on developing countries and in many cases a key obstacle to economic and social progress. Better diagnostics means better health and, in turn, better use of resources, higher productivity and greater opportunities for economic development.
Our aim is to respond to the urgent need for better diagnostic tools for detecting infectious diseases
In particular, we are dedicated to developing and implementing diagnostic tools that are affordable, accurate and suitable for the particular needs of patients in high endemic countries. We are doing this by fostering the transformation of proven biological principles into effective products with demonstrated impact on disease control.
Our focus is currently on three diseases: tuberculosis, malaria and human African trypanosomiasis (HAT), otherwise known as sleeping sickness. We are working to develop diagnostic platforms that can be applied to several diseases - for instance where the same instrument can be used to diagnose not just tuberculosis, but also malaria, human African trypanosomiasis, leishmaniasis, HIV, etc.
We consider that good health can be achieved if the overall health system is viable and accessible
We are keeping a twin-focus on creating more effective technologies that respond to patients needs at all levels of the health system, while strengthening the laboratories in low-income countries becomes a key component of ensuring appropriate use of the new tools.
